HRCM
HRMY icon

Hood River Capital Management’s Harmony Biosciences HRMY Stock Holding History

Hood River Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-318,544
Closed -$10.4M – 133
2023
Q3 		$10.4M Buy
318,544
+5,587
+2% +$194K 0.34% 83
2023
Q2 		$11M Sell
312,957
-765
-0.2% -$26.4K 0.33% 79
2023
Q1 		$10.2M Buy
313,722
+19,855
+7% +$904K 0.33% 75
2022
Q4 		$16.2M Buy
293,867
+1,809
+0.6% +$99.5K 0.59% 57
2022
Q3 		$12.9M Buy
292,058
+6,444
+2% +$314K 0.49% 64
2022
Q2 		$13.9M Sell
285,614
-13,329
-4% -$600K 0.55% 65
2022
Q1 		$14.5M Buy
+298,943
New +$12.2M 0.48% 69

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Hood River Capital Management's HRMY Position: Q4 2023 in Review

Hood River Capital Management sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 318,544 shares — an estimated $10.4M sold.

Hood River Capital Management first reported a position in HRMY in Q1 2022 and held it in 7 quarters. The position peaked at $16.2M in Q4 2022. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

  • Hood River Capital Management reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
  • Hood River Capital Management sold 318,544 Harmony Biosciences shares in Q4 2023, an estimated $10.4M.
  • Hood River Capital Management first reported a position in Harmony Biosciences in Q1 2022 and held it in 7 quarters.
  • Hood River Capital Management's Harmony Biosciences position peaked at $16.2M in Q4 2022.
  • 221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Hood River Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.